Search results for "ORPHAN DRUG|Designated|Treatment of patients with pancreatic cancer" in comments (approximate match)
Showing 1 - 2 of 2 results
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Conditions:
Masitinib is a new orally administered tyrosine kinase inhibitor that targets mast cells and macrophages, important cells for immunity, through inhibiting a limited number of kinases. Based on its unique mechanism of action, masitinib can be develope...
